HSBC Global Research lowered the target price for Sino Biopharm (01177) to HKD4.5 from HKD4.6 and maintained the "buy" rating.
The research house said it expects low-teens growth for revenue and adjusted net profit in 2024e-25e.
etnet榮獲HKEX Awards 2023 「最佳表現證券數據供應商」大獎► 了解詳情